PMGC HoldingsELAB +5.16%8 Days Payable is 136.77 as of Mar. 2026, which is 61% below its 10-year median of 354.03. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, PMGC Holdings ranks better than 65.34% on this metric.
The historical rank and industry rank for PMGC Holdings's Days Payable or its related term are showing as below:
ELAB'
s Days Payable Range Over the Past 10 Years
Min: 176.78 Med: 354.03 Max: 531.28
Current: 218.49
During the past 5 years, PMGC Holdings's highest Days Payable was 531.28. The lowest was 176.78. And the median was 354.03.
ELAB's Days Payable is ranked better than 65.34% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs ELAB: 218.49
PMGC Holdings's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (136.77).
It may suggest that PMGC Holdingsdelayed paying its suppliers.
PMGC Holdings Days Payable Related Terms
PMGC Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for PMGC Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, PMGC Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMGC Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PMGC Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where PMGC Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PMGC Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMGC Holdings (ELAB) has a Days Payable of 136.77 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PMGC Holdings and its competitors. This is 61% below median its historical median of 354.03. Over the past decade, PMGC Holdings' Days Payable has ranged from 176.78 to 531.28. According to the industry distribution chart, PMGC Holdings ranks #243 out of 701 companies in the Biotechnology industry, placing it in the top 34.7%.
Is PMGC Holdings' Days Payable too high?
PMGC Holdings' current Days Payable of 136.77 is 61% below median its 10-year median of 354.03. Over the past 10 years, this metric has ranged from a low of 176.78 to a high of 531.28. The Biotechnology industry median Days Payable is 112.84. PMGC Holdings' value of 136.77 is 21.2% above this industry median. Based on the distribution chart, PMGC Holdings ranks #243 out of 701 companies in the Biotechnology industry, which is above the industry midpoint. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Days Payable compare to MBIO and PCSA?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #243 out of 701 companies for Days Payable. This puts PMGC Holdings in the upper half of its industry. The industry median Days Payable is 112.84. PMGC Holdings' value of 136.77 is 21.2% above this benchmark. Historically, PMGC Holdings' own Days Payable has ranged from 176.78 to 531.28 over the past decade. While the company's 10-year median is 354.03 vs. the industry median of 112.84, PMGC Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMGC Holdings's current Days Payable of 136.77 is 21.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PMGC Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMGC Holdings's current Days Payable is 136.77, which is 61% below median its own 10-year median of 354.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Days Payable of 136.77. The current Days Payable is 136.77, which is 61% below median its 10-year median of 354.03 and 21.2% above the Biotechnology industry median of 112.84. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Days Payable is 136.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score
Get the complete analysis for ELAB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELAB has been successfully added to your 
